HappeningToo topic
Glipizide reports
Browse community reports connected to Glipizide. These reports can show that other people are describing similar experiences, but they do not prove that Glipizide caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
41 problems
Abdominal Discomfort while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and abdominal discomfort appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and abdominal distension appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and abdominal pain upper appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and abdominal pain appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and acid reflux appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and alopecia appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and anxiety appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and back pain appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and constipation appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and cough appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and decreased appetite appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and dehydration appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and diarrhea appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and dizziness appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and dyspepsia appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and excessive sweating appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and fatigue appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and feeling abnormal appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and flatulence appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and flushing appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and headache appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and hypotension appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and insomnia appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and itching appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and malaise appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and muscle spasms appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and muscular weakness appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and myalgia appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and nausea appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and pain appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and peripheral swelling appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and rash appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and shortness of breath appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and sleepiness appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and tingling or pins and needles appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and tremor appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and vision blurred appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and vomiting appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and weakness appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and weight decreased appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Glipizide
FDA FAERS contains adverse-event reports in which Glipizide and weight increased appear together. This does not establish that Glipizide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →